Skip to main content
. 2017 Jun 21;65(6):553–564. doi: 10.1007/s00005-017-0479-1

Fig. 2.

Fig. 2

Comparison of dominant TCRs expressed by effector and regulatory CD4+ T cells in healthy and tumor-bearing TCRmini mice. The influence of the tumor on TCR repertoire of CD4+Teffs and Tregs. The frequencies of 35 most dominant TCRs from CD4+Teffs and Tregs from indicated sites of B16-Ep tumor-bearing (black bars) mice in comparison to TCRs present among circulating lymphocytes of healthy non-tumor-bearing control TCRmini mice (gray bars)